Ligand validation:2WSB

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 2WSB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WSB_NAD_C_500	100%	17%	0.041	0.984	1.79	1.8	5	10	0	0	100%	1
2WSB_NAD_A_500	100%	13%	0.044	0.985	1.91	2.09	11	10	1	0	100%	1
2WSB_NAD_D_500	100%	34%	0.041	0.982	1.3	1.31	4	6	2	0	100%	1
2WSB_NAD_B_500	98%	17%	0.049	0.972	1.43	2.13	6	10	7	0	100%	1
2WDZ_NAD_D_257	91%	19%	0.083	0.971	1.97	1.47	6	9	0	0	100%	1
3LQF_NAD_A_257	24%	30%	0.199	0.829	1.8	1.03	5	2	3	0	100%	1
3CMC_NAD_O_407	100%	18%	0.022	0.996	1.63	1.92	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.